Gulla, A.; Andriusaityte, U.; Zdanys, G.T.; Babonaite, E.; Strupas, K.; Kelly, H.
The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Medicina 2022, 58, 467.
https://doi.org/10.3390/medicina58040467
AMA Style
Gulla A, Andriusaityte U, Zdanys GT, Babonaite E, Strupas K, Kelly H.
The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Medicina. 2022; 58(4):467.
https://doi.org/10.3390/medicina58040467
Chicago/Turabian Style
Gulla, Aiste, Urte Andriusaityte, Gabrielius Tomas Zdanys, Elena Babonaite, Kestutis Strupas, and Helena Kelly.
2022. "The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy" Medicina 58, no. 4: 467.
https://doi.org/10.3390/medicina58040467
APA Style
Gulla, A., Andriusaityte, U., Zdanys, G. T., Babonaite, E., Strupas, K., & Kelly, H.
(2022). The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Medicina, 58(4), 467.
https://doi.org/10.3390/medicina58040467